BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33786679)

  • 1. Relationship Between Early Postoperative Change in Total Psoas Muscle Area and Long-term Prognosis in Esophagectomy for Patients with Esophageal Cancer.
    Matsui K; Kawakubo H; Hirata Y; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
    Ann Surg Oncol; 2021 Oct; 28(11):6378-6387. PubMed ID: 33786679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle loss in the postoperative acute phase after esophageal cancer surgery as a new prognostic factor.
    Maeda N; Shirakawa Y; Tanabe S; Sakurama K; Noma K; Fujiwara T
    World J Surg Oncol; 2020 Jun; 18(1):143. PubMed ID: 32591002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer.
    Takahashi K; Watanabe M; Kozuki R; Toihata T; Okamura A; Imamura Y; Mine S; Ishizuka N
    Ann Surg Oncol; 2019 Oct; 26(11):3727-3735. PubMed ID: 31313039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer.
    Nakashima Y; Saeki H; Hu Q; Tsuda Y; Zaitsu Y; Hisamatsu Y; Ando K; Kimura Y; Oki E; Mori M
    Ann Surg Oncol; 2020 Feb; 27(2):492-498. PubMed ID: 31549319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Preoperative Skeletal Muscle Mass and Nutritional Status on Short-and Long-Term Outcomes After Esophagectomy for Esophageal Cancer: A Retrospective Observational Study : Impact of Psoas Muscle Mass and Body Mass on Esophagectomy.
    Shichinohe T; Uemura S; Hirano S; Hosokawa M
    Ann Surg Oncol; 2019 May; 26(5):1301-1310. PubMed ID: 30725311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy.
    Ishida T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Mori M; Doki Y
    Surgery; 2019 Dec; 166(6):1041-1047. PubMed ID: 31607486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative pneumonia causes the loss of skeletal muscle volume and poor prognosis in patients undergoing esophagectomy for esophageal cancer.
    Fujishima S; Tsujimoto H; Nagata K; Sugasawa H; Nomura S; Ito N; Harada M; Sugihara T; Ishibashi Y; Kouzu K; Shinmoto H; Kishi Y; Ueno H
    Gen Thorac Cardiovasc Surg; 2021 Jan; 69(1):84-90. PubMed ID: 32914386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantity and Quality of Skeletal Muscle as an Important Predictor of Clinical Outcomes in Patients with Esophageal Cancer Undergoing Esophagectomy after Neoadjuvant Chemotherapy.
    Ishida T; Makino T; Yamasaki M; Yamashita K; Tanaka K; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Eguchi H; Doki Y
    Ann Surg Oncol; 2021 Nov; 28(12):7185-7195. PubMed ID: 33876359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term variation in psoas muscle mass index is affected by short-term loss after esophagectomy in survivors of esophageal cancer.
    Nishimura E; Kawakubo H; Matsuda S; Fukuda K; Nakamura R; Kitagawa Y
    Dis Esophagus; 2023 Feb; 36(3):. PubMed ID: 36073920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of long-term tube feeding intervention in preventing skeletal muscle loss after minimally invasive esophagectomy.
    Kato T; Oshikiri T; Koterazawa Y; Goto H; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Surg Today; 2024 Jun; 54(6):606-616. PubMed ID: 38150018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Sarcopenia on Unplanned Readmission and Survival After Esophagectomy in Patients with Esophageal Cancer.
    Makiura D; Ono R; Inoue J; Fukuta A; Kashiwa M; Miura Y; Oshikiri T; Nakamura T; Kakeji Y; Sakai Y
    Ann Surg Oncol; 2018 Feb; 25(2):456-464. PubMed ID: 29214454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Preoperative Skeletal Muscle Measure as a Predictor of Postoperative Complications, Long-Term Survival and Tumor Recurrence for Patients with Gastric Cancer After Radical Gastrectomy.
    Lu J; Zheng ZF; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM
    Ann Surg Oncol; 2018 Feb; 25(2):439-448. PubMed ID: 29181681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
    Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
    Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased total psoas muscle area after neoadjuvant therapy is a predictor of increased mortality in patients undergoing oesophageal cancer resection.
    Yassaie SS; Keane C; French SJH; Al-Herz FAJ; Young MK; Gordon AC
    ANZ J Surg; 2019 May; 89(5):515-519. PubMed ID: 30959566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer.
    Fidler MJ; Borgia JA; Bonomi PD; Shah P
    Ann Surg Oncol; 2019 Nov; 26(12):3807-3808. PubMed ID: 31471841
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
    Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
    Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer.
    Nakashima Y; Saeki H; Nakanishi R; Sugiyama M; Kurashige J; Oki E; Maehara Y
    Ann Surg; 2018 Jun; 267(6):1100-1104. PubMed ID: 28437312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Sarcopenia in Patients with Esophagogastric Junction Cancer or Upper Gastric Cancer.
    Kudou K; Saeki H; Nakashima Y; Edahiro K; Korehisa S; Taniguchi D; Tsutsumi R; Nishimura S; Nakaji Y; Akiyama S; Tajiri H; Nakanishi R; Kurashige J; Sugiyama M; Oki E; Maehara Y
    Ann Surg Oncol; 2017 Jul; 24(7):1804-1810. PubMed ID: 28224363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer.
    Ida S; Watanabe M; Yoshida N; Baba Y; Umezaki N; Harada K; Karashima R; Imamura Y; Iwagami S; Baba H
    Ann Surg Oncol; 2015 Dec; 22(13):4432-7. PubMed ID: 25862583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of sarcopenia in patients undergoing esophagectomy for superficial esophageal squamous cell carcinoma.
    Oguma J; Ozawa S; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 30809629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.